Skip to main content
Caplight Logo









Coding Bio

Coding Bio

Private
OxfordHealthcare & Life Scienceshttps://www.coding.bio/

Last Round

Seed

Feb 13, 2026

Total Funding Raised

$5.91M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Coding Bio is a biotechnology company that provides an AI-assisted platform for cell therapy development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoveryimmunotherapyAI drug discoveryprotein engineeringCAR-TBiTEhigh-throughput screeningprotein language modelsgenerative biologyoncologyin silico drug designbiotech R&Dmodular therapyAI-first biotechcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coding Bio Comparables

Compare Coding Bio with similar companies based on industry and business-model similarity.

Coding Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BigHat Biosciences
77%
LabGenius Therapeutics
77%
AbSci
72%

Coding Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 13, 2026
GrantAug 28, 2024
GrantJan 1, 2023
SeedNov 1, 2022
GrantMay 1, 2022

Key People

Founding team and executive leadership

Yulia Lampi

Chief Scientific Officer Founder

Founding Team

Simon Bornschein

Founder CEO

Founding Team

Nils Y. Hammerla

Chief Technology Officer

Executive Team

Coding Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 2, 2026

    Grew 20% QoQ, from 20 to 24 employees.

  • Jul 25, 2026

    Monthly visitors increased 1074% MoM, reaching 1.4K.

Coding Bio Filings

Explore SEC and related filing metadata, where available.

Coding Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Coding Bio's valuation, stock price, and market status.

Is Coding Bio a public or private company?

Coding Bio is a private company.

What is the current stock price of Coding Bio?

Coding Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Coding Bio worth (valuation)?

Valuation information for Coding Bio is not publicly available.

Can I buy Coding Bio stock?

Coding Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Coding Bio's last funding round?

Coding Bio's most recent funding round was Grant on August 28, 2024.

Who are the main investors in Coding Bio?

Key investors in Coding Bio include Start Codon, Innovate UK.

Will Coding Bio IPO soon?

No public IPO plans have been announced for Coding Bio.

How can I track Coding Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Coding Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOxford
Employee Range21
Year Founded2021
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?